freezers, having a revenue share of more than 80%. The larger share can be attributed to the high demands
pertaining to bio-banks and the extensive use and importance of the aforementioned products in bio-
preservation. Media segment which includes home brewed and pre-formulated media is projected to witness a
healthy growth as a consequence of the increased demands of tissues, cells and other materials in bio banking
and advanced products in regenerative medicines. Furthermore, the high share and preference of home brewed
media in terms of bio-storage can be attributed to its cost-efficiency and effectiveness in comparison to pre-
formulated media.
Application Insights
The major application analyzed in the study comprised of drug discovery, bio-banking and regenerative
medicines. Moreover, the further segmentation of bio-banking includes veterinary IVF, human sperm and
human eggs. Bio-banking segment held the largest share of 72.5% in 2014. Rising awareness related to
preservation of stem cells, use of assisted technology for reproduction in animals and increasing number of
sperm and egg banks are anticipated to drive the growth. Additionally, the expected rise in the revenue share
of the segment can be attributed to advent of new techniques used for preservation of cells for a longer span
of time. Regenerative medicine is considered to be the fastest growing segment owing to the high demand
pertaining to efficient and specialized techniques for bio-storage. Moreover, huge amount of investments by
non-government or government organizations in the field of regenerative cell therapy research is projected to
boost the growth of the overall market.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/biopreservation-market
Cell providers Insights
The segment of cell providers can be analyzed on basis of tumor cells, hESC, iPSC, MSC, CD19+, and CD34+. The
largest market share was held by tumor cells in terms of volume in 2014 as a consequence of their wide array
of application in treatment, diagnosis and R&D of the most prevalent forms of cancer. However, the fastest
growing segment is predicted to be the iPSC segment throughout the forecast period because of their promising
application in regenerative medicines owing to their high propagating capacity.
Regional Insights
Key market in 2014 was the North American having a revenue share of more than 45% owing to the innovative
drug developments and therapies pertaining to the biomedical research. Also, continuous rise in the population
base with chronic and acute disorders requiring treatment and diagnosis in the region is further drive the
revenue generation. Asia Pacific region is expected to show a considerable growth rate over the forecast period